Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ADAR1 promotes systemic sclerosis via modulating classic macrophage activation

Frontiers in Immunology(2022)10.3389/fimmu.2022.1051254Source: DataRank Database

ADAR1 promotes systemic sclerosis via modulating classic macrophage activation is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.71)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Dunpeng Cai ORCID,Shi‐You Chen,Chenming Sun ORCID

Live enrichment

PubMed:36532023 PMC:PMC9751044 OpenAlex:https://openalex.org/W4310490723

NHLBI NIH HHS

Grant: R01 HL147313

NHLBI NIH HHS

Grant: R01 HL119053

National Institutes of Health

Grant: 5R01HL147313-04

Dedicator of cytokinesis 2 in abdominal aortic aneurysm

National Institutes of Health

Grant: 1R01HL119053-01A1

Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling

National Institutes of Health

National Natural Science Foundation of China

China Postdoctoral Science Foundation

FWCI

0.71

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1051254/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1051254/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1051254/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1051254/full

journalhttps://doi.org/10.3389/fimmu.2022.1051254

Fields of Study

RNA regulation and diseaseAmyotrophic Lateral Sclerosis ResearchSystemic Sclerosis and Related DiseasesMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesMiceAnimalsMacrophage ActivationSclerosisMice, KnockoutScleroderma, SystemicRNABleomycinAdenosine Deaminase

MeSH Terms

Adenosine DeaminaseAnimalsBleomycinMacrophage ActivationRNAScleroderma, SystemicSclerosisMice, KnockoutMice

Keywords

MacrophageMacrophage activation syndromeMedicineImmunologyMultiple sclerosisNeuroscienceBiologyGeneticsIn vitroMacrophage activationIL-1βNF-κBSystemic SclerosisAdar1Mice, KnockoutSclerosisScleroderma, SystemicAdenosine DeaminaseRC581-607MiceBleomycinImmunology and AllergyAnimalsRNAImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being